Skip to content

Perioperative analgesia with a buprenorphine transdermal patch for foot and ankle surgery: A prospective, randomized, controlled study

Perioperative analgesia with a buprenorphine transdermal patch for foot and ankle surgery: A prospective, randomized, controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17012931
Enrollment
Unknown
Registered
2017-10-10
Start date
2017-11-01
Completion date
Unknown
Last updated
2017-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foot and ankle disease, like hallux valgus

Interventions

BDTS group:The patients in test group administered BTDS 2 days before the operation until 5 days after the operation
PCA group:The patients in control group administered postoperative analgesia with PCIA immediately, and last two days.

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Males or females aged 18 years and more; 2. Subjects must suffered to the foot and ankle surgery; 3. Subjects must be able to understand the study procedures and assessment, and agree to participate in the study by giving written informed consent.

Exclusion criteria

Exclusion criteria: 1. The patients have severe liver and kidney dysfunction and blood system dysfunction; 2. The patients have angina pectoris in nearly 6 months; 3. The patients have congestive heart failure and arrhythmia; 4. The patients have adverse cardiovascular and cerebrovascular events and have coronary artery bypass grafting or interventional operation in nearly 3 months; 5. The patients have taken opioids preoperative; 6. The patients have joint infection or systemic infection; 7. The patients have chronic pain caused by rheumatoid such as arthritis or bone tumours; 8. Other diseases or conditions that do not fit into the study by the investigator.

Design outcomes

Primary

MeasureTime frame
VAS score of perioperative period;AOFAS;

Secondary

MeasureTime frame
rescue analgesia;adverse effects;

Countries

China

Contacts

Public ContactLiu Hua

Xiangya Hospital, Central South University

liuhua345@163.com+86 13973168455

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026